Healthpeak Properties (NYSE:DOC) Price Target Raised to $24.00

Healthpeak Properties (NYSE:DOC) had its price objective hoisted by research analysts at Royal Bank Of Canada from $21.00 to $24.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s price target points to a potential upside of 14.14% from the company’s current price.

Other equities analysts also recently issued reports about the company. Scotiabank upped their target price on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Wells Fargo & Company lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 15th. Robert W. Baird boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. BMO Capital Markets increased their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, June 15th. Finally, Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Four research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $21.15.

Healthpeak Properties Stock Performance

NYSE:DOC traded down $0.38 during trading hours on Monday, hitting $21.03. 1,169,914 shares of the company were exchanged, compared to its average volume of 8,571,724. The stock has a market capitalization of $14.50 billion, a price-to-earnings ratio of 60.07, a PEG ratio of 3.31 and a beta of 1.01. Healthpeak Properties has a 52-week low of $15.70 and a 52-week high of $22.95. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. The company’s 50 day moving average price is $21.20 and its 200-day moving average price is $18.81.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. The business had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts forecast that Healthpeak Properties will post 1.76 earnings per share for the current year.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.23% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds have recently added to or reduced their stakes in the business. Clearstead Trust LLC lifted its holdings in shares of Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 543 shares during the period. Advocate Investing Services LLC acquired a new stake in Healthpeak Properties during the fourth quarter worth about $26,000. WPG Advisers LLC raised its position in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after acquiring an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in Healthpeak Properties during the second quarter valued at approximately $33,000. Finally, Clearstead Advisors LLC raised its position in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after acquiring an additional 1,216 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.